Make ABN Newswire your homepage | Add to Favourites
 CHINESE SIMPLE   CHINESE TRAD     JAPANESE     KOREAN
 ENGLISH    ARABIC    EUROPE
 
  Home    |   Media Partners    |    About Us   |   Contact Us
 
Home News
 

Perth, Oct 1, 2008 (ABN Newswire) - Stirling Products (ASX:STI) advises shareholders that it launched PetQuench(tm), the first of its companion animal products, at one of Canada's largest pet shows last weekend. PetQuench(tm) was released onto the Canadian market through Stirling Animal Health at the prestigious PIJAC National Industry Trade Show in Ontario, Canada.

Key Points:

- PetQuench(tm) launched under Stirling branding in Canada

- PetQuench(tm) to be launched under Stirling branding in USA in October

- Sales expectation of up to $3.5-5.0 million (Canadian) in next two years from North America

CEO and Managing Director of Stirling Products, Dr Calvin London said, "Since the announcement in August that we had acquired the rights to this product, we have been working hard to put the product back onto the market. I am pleased that we have to-date, met our deadlines for manufacture and offered some great deals for trade show attendees to reintroduce this product as a Stirling Animal initiative".

PetQuench(tm) will also be launched to the United States market in early October (October 3-5) at the H.H. Backer's Pet Industry Christmas Trade Show in Chicago, USA. Last year this trade show attracted 969 manufacturers and more than 9,000 retail buyers.Vice President of Marketing for Stirling Animal Health, Mr Derrick Walker said about the trade show, "We've relaunched Stirling Animal Health's PetQuench(tm) Fortified Water to a strong retailer, distributor and media response. Sign-ups were steady for the Canadian market. We also had supply enquiries for the US, European and Japanese markets. We will be negotiating new distributor agreements and pressing ahead, even as we prepare to attend the US Backer's Trade Show in Chicago in first weeks of October".

PetQuench(tm) is fortified water that increases water consumption for dogs and cats. This is particularly useful for animals that are dehydrated or recovering from surgery, or as a simple aid to get pets to drink more water. Dogs and cats are becoming increasingly susceptible to urinary tract and kidney disorders in response to inadequate water consumption.

The company is projecting sales revenue of up to $3.5-5.0 million (Canadian) from its North American sales of this product over the next two years and intends to release the product in Australia by the end of the first quarter in 2009.

Australia has one of the highest incidences of pet ownership with over 63% of all households owning either a dog or a cat. Added to the increasing incidence of pet ownership in South East Asia, China and Japan, Stirling Animal Health is hoping to become an integral part of the $7 billion expenditure forecast on dog and cat foods and food related items.


About STIRLING PRODUCTS LIMITED

Stirling Products is developing patented animal growth agents that increase meat production, therefore improving the production efficiency of livestock animals, while decreasing fat accumulation for the benefit of consumers. The Stirling growth agents are under development for swine, poultry, cattle and sheep for global markets and are being positioned to take a major role in reducing the global use of antibiotics and steroid hormones in livestock. Stirling is also developing veterinary medications for heaves in horses through its joint venture in Europe (Pulmovet ApS, www.pulmovet.com) and an obesity treatment in companion animals.

Stirling Products recently acquired a Canadian company Progressive BioActives Incorporated (PBI) under its North American subsidiary, Stirling Products NA Inc. PBI is part of the Bioscience cluster established on located Prince Edward Island, Canada. PBI's lead product ProVale, is the latest high purity beta glucan extract that has been designed as an alternative tool for sustainable livestock management in face of increasing viral disease challenges where antibiotics have no or limited application. ProVale is available for targeted applications in swine, poultry and farmed aquaculture with a future focus on further developing applications for companion animals (e.g. horses, dogs, cats and reptiles).


  Related Companies

>>> STIRLING PRODUCTS LIMITED

 

 
 
Stirling Products Limited (ASX:STI) Launches Animal Product PetQuench In North America
 
STIRLING PRODUCTS LIMITED
2008.11.10  13:29
Stirling Products (ASX:STI) Consolidates Licensing Deals

2008.11.07  12:04
Stirling Products (ASX:STI) Gets First Approval For Obesity Patent

2008.09.11  13:19
Stirling Products (ASX:STI) Announces Consolidation Of Stirling North American Operation

2008.08.14  13:35
Stirling Products (ASX:STI) Signs First Product For Companion Animals

2008.07.28  16:57
Stirling Products (ASX:STI) Gets Australian Patent For Heaves In Horses

 
Asia Business News
Submit Press
News Alerts by Email
Home | Contact Us | About Us
Copyright 2008 Asia Business News Ltd.